Interleukin 7 Immunotherapy and Lymphocyte Counts Among Patients With Severe COVID-19

This case series examines whether interleukin 7 (IL-7) is associated with restored host protective immunity in patients with severe coronavirus disease 2019 (COVID-19) and immunosuppression.

Read the full article here

Related Articles